参考文献/References:
[1] Masarone M, Federico A, Abenavoli L,et al. Non alcoholic fatty liver: epidemiology and natural history[J].Rev Recent Clin Trials,2014,9(3):126-133.
[2] Sung KC, Ryan MC, Kim BS,et al. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults[J]. Diabetes Care, 2007, 30(8):2113-2118.
[3] Grassi D, Ferri L, Desideri G, et al. Chronic hyperuricemia, uric acid deposit and cardiovascular risk [J]. Curr Pharm Des,2013,19:4930-4937.
[4] Lonardo A, Loria P, Leonardi F,et al. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease.A case-control study[J]. Dig Liver Dis,2002,34(3):204-211.
[5] Lee S, Jin Kim Y, Yong Jeon T,et al. Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study[J]. Scand J Gastroenterol,2006,41(5):566-572.
[6] Li Y, Xu C, Yu C,et al. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study[J]. J Hepatol,2009,50(5):1029-1034.DOI:10.1016/j.jhep.2008.11.021.
[7] Xie Y, Wang M, Zhang Y,et al. Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men[J].PLoS One,2013,8(7):e67152.DOI:10.1371/journal.pone.0067152. Print 2013.
[8] Lin H, Li Q, Liu X,et al. Liver fat content is associated with elevated serum uric acid in the Chinese middle-aged and elderly populations: Shanghai Changfeng Study[J]. PLoS One, 2015,10(10): e0140379.DOI:10.1371/journal.pone.0140379. eCollection 2015.
[9] Cai W, Wu X, Zhang B,et al. Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China[J].Arq Bras Endocrinol Metabol,2013,57(8):617-622.
[10] Sirota JC, McFann K, Targher G,et al. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey[J].Metabolism,2013,62(3):392-399.DOI:10.1016/j. metabol. 2012.08.013.
[11] Sogabe M, Okahisa T, Taniguchi T,et al. Light alcohol consumption plays a protective role against non-alcoholic fatty liver disease in Japanese men with metabolic syndrome[J].Liver Int,2015,35(6):1707-1714.DOI:10.1111/liv.12754.
[12] Petta S, Cammà C, Cabibi D,et al. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease[J].Aliment Pharmacol Ther,2011,34(7):757-766. DOI: 10.1111/j.1365-2036.2011.04788.x.
[13] Lee JW, Cho YK, Ryan M,et al. Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study[J].Gut Liver, 2010,4(3):378-383. DOI: 10.5009/gnl.2010.4.3.378.
[14] Xu C, Yu C, Xu L,et al. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study[J].PLoS One,2010,5(7):e11578. DOI: 10.1371/journal.pone.0011578.
[15] Xu C, Wan X, Xu L,et al. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds[J].J Hepatol,2015,62(6):1412-1419.DOI:10.1016/j.jhep.2015.01.019.
[16] Nakatsu Y, Seno Y, Kushiyama A,et al.The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model[J]. Am J Physiol Gastrointest Liver Physiol,2015,309(1):G42-G51.DOI:10.1152/ajpgi.00443.2014.
[17] Li X, Huang W, Gu J,et al. SREBP-1c overactivates ROS-mediated hepatic NF-κB inflammatory pathway in dairy cows with fatty liver[J].Cell Signal,2015,27(10):2099-2109. DOI: 10.1016/j.cellsig.2015.07.011.
[18] Choi YJ, Shin HS, Choi HS,et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes[J].Lab Invest, 2014,94(10):1114-1125.DOI:10.1038/labinvest.2014.98.
[19] Lanaspa MA, Sanchez-Lozada LG, Choi YJ,et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver[J].J Biol Chem,2012,287(48):40732-40744. DOI: 10.1074/jbc.M112.399899.
[20] Xu C. Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back[J].Hepatol Int, 2015,[Epub ahead of print].
[21] Zhang JX, Zhang YP, Wu QN,et al. Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes[J]. Endocrine,2015,48(1):135-142. DOI: 10.1007/s12020-014-0239-5.
相似文献/References:
[1]曹涵,曲伸.过氧化物酶体增殖物活化受体与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2014,(06):404.[doi:10.3760/cma.j.issn.1673-4157.2014.06.012]
Cao Han,Qu Shen..Peroxisome proliferator-activated receptors and non-alcoholic fatty liver diseases[J].International Journal of Endocrinology and Metabolism,2014,(02):404.[doi:10.3760/cma.j.issn.1673-4157.2014.06.012]
[2]胡雅琴,包玉倩.维生素D对非酒精性脂肪性肝病的保护作用[J].国际内分泌代谢杂志,2014,(06):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
Hu Yaqin,Bao Yuqian..Protective effect of vitamin D on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(02):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
[3]黄江燕,董力,邹贵勉,等.广西城市社区居民高尿酸血症流行病学调查[J].国际内分泌代谢杂志,2014,(01):5.[doi:10.3760/cma.j.issn.1673-4157.2014.01.002]
Huang Jiangyan*,Dong Li,Zou Guimian,et al.Epidemiological survey of hyperuricemia in the Guangxi urban community residents[J].International Journal of Endocrinology and Metabolism,2014,(02):5.[doi:10.3760/cma.j.issn.1673-4157.2014.01.002]
[4]王靖宇,常宝成.高尿酸血症/痛风流行病学特点及危险因素[J].国际内分泌代谢杂志,2016,36(02):78.[doi:10.3760/cma.j.issn.1673-4157.2016.02.002]
Wang Jingyu,Chang Baocheng..Epidemiological characteristics and risk factors of hyperuricemia/gout[J].International Journal of Endocrinology and Metabolism,2016,36(02):78.[doi:10.3760/cma.j.issn.1673-4157.2016.02.002]
[5]李明珍,聂秀玲,孙丽荣.高尿酸血症与糖代谢异常的关系[J].国际内分泌代谢杂志,2016,36(04):217.[doi:10.3760/cma.j.issn.1673-4157.2016.04.01]
Li Mingzhen,Nie Xiuling,Sun Lirong.Relationship between hyperuricemia and abnormalities of glucose metabolism[J].International Journal of Endocrinology and Metabolism,2016,36(02):217.[doi:10.3760/cma.j.issn.1673-4157.2016.04.01]
[6]刘彤,杨亚娟.高尿酸血症与心房颤动的关系[J].国际内分泌代谢杂志,2016,36(04):220.[doi:10.3760/cma.j.issn.1673-4157.2016.04.02]
Liu Tong,Yang Yajuan.Relationship between hyperuricemia and atrial fibrillation[J].International Journal of Endocrinology and Metabolism,2016,36(02):220.[doi:10.3760/cma.j.issn.1673-4157.2016.04.02]
[7]张洁,邸阜生.运动防治非酒精性脂肪性肝病的机制[J].国际内分泌代谢杂志,2016,36(06):404.[doi:10.3760/cma.j.issn.1673-4157.2016.06.12]
Zhang Jie,Di Fusheng..Mechanism of exercise on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2016,36(02):404.[doi:10.3760/cma.j.issn.1673-4157.2016.06.12]
[8]刘华英,顾丹阳,邵加庆.高尿酸血症与内皮功能障碍[J].国际内分泌代谢杂志,2016,36(06):412.[doi:10.3760/cma.j.issn.1673-4157.2016.06.14]
Liu Huaying,Gu Danyang,Shao Jiaqing..Hyperuricemia and endothelial dysfunction[J].International Journal of Endocrinology and Metabolism,2016,36(02):412.[doi:10.3760/cma.j.issn.1673-4157.2016.06.14]
[9]张雅楠,郗光霞,杨翠萍,等.自噬在非酒精性脂肪性肝病中的变化及作用[J].国际内分泌代谢杂志,2017,37(01):11.[doi:10.3760/cma.j.issn.1673-4157.2017.01.03]
Zhang Yanan*,Xi Guangxia,Yang Cuiping,et al.The change and function of autophagy in nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2017,37(02):11.[doi:10.3760/cma.j.issn.1673-4157.2017.01.03]
[10]曹雯,孙洪平,褚晓秋,等.生活方式干预与高尿酸血症[J].国际内分泌代谢杂志,2017,37(03):172.[doi:10.3760/cma.j.issn.1673-4157.2017.03.007]
Cao Wen,Sun Hongping,Chu Xiaoqiu,et al.Lifestyle intervention and hyperuricemia[J].International Journal of Endocrinology and Metabolism,2017,37(02):172.[doi:10.3760/cma.j.issn.1673-4157.2017.03.007]